|
Volumn 49, Issue 3, 2000, Pages 213-218
|
A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas
|
Author keywords
ACNU; Cisplatin; Etoposide; Gliomas; Phase II study
|
Indexed keywords
CISPLATIN;
ETOPOSIDE;
NIMUSTINE;
SEROTONIN ANTAGONIST;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERANCE;
FEMALE;
GLIOBLASTOMA;
HUMAN;
MALE;
NAUSEA;
NEPHROTOXICITY;
PHASE 2 CLINICAL TRIAL;
SURVIVAL TIME;
TREATMENT OUTCOME;
TUMOR GROWTH;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CEREBELLAR NEOPLASMS;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
ETOPOSIDE;
FEMALE;
GLIOMA;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NIMUSTINE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 0034486814
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1006486528418 Document Type: Article |
Times cited : (7)
|
References (18)
|